查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1788207

全球無創冠狀動脈影像市場

Non-invasive Coronary Imaging
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 274 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年全球無創冠狀動脈成像市場規模將達到 5.306 億美元

全球非侵入性冠狀動脈影像市場規模預計在2024年為3.923億美元，到2030年將達到5.306億美元，在2024-2030年的分析期內，複合年成長率為5.2%。心臟超音波圖是本報告分析的細分市場之一，預計其複合年成長率為3.5%，到分析期結束時市場規模將達到2.048億美元。心臟電腦斷層掃描（CT）在分析期間的複合年成長率預計為6.6%。

美國市場規模估計為 1.069 億美元，中國市場預計複合年成長率為 7.9%

美國非侵入性冠狀動脈影像市場規模預計在2024年達到1.069億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到1.04億美元，在2024-2030年的分析期間內，複合年成長率為7.9%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為2.6%和5.0%。在歐洲，預計德國市場的複合年成長率為3.3%。

全球無創冠狀動脈影像市場—主要趨勢與促進因素摘要

非侵入性冠狀動脈影像將如何改變心血管診斷的模式？

非侵入性冠狀動脈影像正在徹底改變心血管診斷的格局，為臨床醫生提供一種更安全、更快速、更準確的方法來評估冠狀動脈疾病 (CAD)，而無需進行導管操作。傳統冠動脈攝影術(CAI) 雖然有效，但它是侵入性的，並且給患者帶來很大的風險，包括潛在的血管損傷、顯影劑過敏反應以及術後恢復時間。相較之下，冠狀動脈電腦斷層掃描 (CCTA)、心臟磁振造影(CMR) 和正子斷層掃描 (PET) 等非侵入性技術能夠高解析度可視化冠狀血管，同時降低手術風險。這些技術對於檢測斑塊堆積、評估狹窄和評估整體心臟功能至關重要。患者可受益於更短的檢查時間、更少的不適感和更短的住院時間，而醫生可以獲得詳細的解剖和功能數據，使他們能夠做出更明智的治療決策。此外，非侵入性影像工具已成為預防心臟病學的必備工具，因為它們能夠在症狀出現之前很久就發現亞臨床動脈粥狀硬化。功能性評估的整合，例如基於CT的血流儲備分數（FFR-CT），也正在彌合解剖圖像與生理學見解之間的差距，從而能夠更準確地識別導致缺血的病變。心血管疾病仍然是全球最大的死亡原因，預計未來非侵入性影像在早期發現和疾病管理中的作用將進一步增強。

科技在提高診斷準確性和效率方面發揮什麼作用？

影像技術的進步在提高非侵入性冠狀動脈成像解決方案的可靠性和普及性方面發揮了核心作用。 CT掃描儀的進步——更快的掃描速度、更低的輻射劑量和更高的空間解析度——使得冠狀動脈CT血管攝影成為評估疑似冠狀動脈疾病患者的第一線工具。同時，心臟MRI正被廣泛用於評估心肌灌注、心肌活力和纖維化，而無需患者暴露於電離輻射。人工智慧和機器學習與成像平台的整合進一步提高了診斷準確性，實現了基於大規模數據分析的自動化狹窄檢測、斑塊表徵和風險分層。這些技術也簡化了工作流程，使放射科醫師和心臟科醫師能夠更快、更一致地解讀掃描結果。雙能量CT和光子計數CT是下一代影像創新技術，可增強組織對比度並減少先前阻礙冠狀動脈可視化的偽影。此外，負荷心電圖 (CMR) 和正子斷層掃描 (PET) 等功能性影像技術如今能夠高度準確地洞察心肌血流和灌注障礙，這對於確定是否需要重組至關重要。與電子健康記錄(EHR) 和雲端基礎共用系統的互通性實現了無縫資料整合，甚至第二意見諮詢。這些技術飛躍不僅提高了準確性，還重塑了診斷途徑，使其更快捷、更方便患者、更個人化。

臨床實務和病患偏好的變化是否推動了採用？

不斷變化的臨床實踐以及不斷變化的患者期望在非侵入性冠狀動脈成像方式日益成長的需求中發揮關鍵作用。循環系統和全科醫生擴大推薦非侵入性影像作為穩定性胸痛和風險評估的第一線診斷方法，尤其是越來越多的證據支持其臨床有效性。美國心臟病學會和歐洲心臟病學會等知名組織發布的指南越來越傾向於非侵入性操作，因為事實證明，非侵入性操作可以減少不必要的侵入性操作及其相關併發症。從患者的角度來看，方便、減少焦慮以及對更快康復的渴望意味著患者比以往任何時候都更有可能選擇非侵入性的門診診斷。這對於老年患者和患有多種併發症的患者尤其重要，因為侵入性檢測對他們來說風險更高。非侵入性選項在遠端醫療和遠距保健模式中也更具擴充性，從而可以將診斷服務擴展到農村和服務不足地區的患者。此外，糖尿病、肥胖症和高血壓等生活方式相關風險因素的增多，推動了對更早、更頻繁的心血管篩檢的需求，尤其是在無症狀高風險族群中。為了應對這一轉變，醫院和影像中心正在投資多重模式影像系統，並擴展循環系統服務線以應對門診診斷。所有這些趨勢都代表著醫療服務提供者策略和患者心態的重大轉變，支持全球醫療系統長期採用非侵入性冠狀動脈成像。

推動非侵入性冠狀動脈影像市場快速成長的因素是什麼？

非侵入性冠狀動脈影像市場的成長受到多種因素的推動，包括技術創新、臨床路徑的演變以及醫療服務體系的轉變。其中最重要的促進因素之一是成像平台的進步，這些平台能夠即時、詳細地顯示冠狀動脈的解剖結構和功能，並避免了侵入性手術固有的風險。掃描器速度、影像解析度和後處理軟體的不斷改進顯著擴展了這些成像方式的臨床效用。在最終用戶方面，醫療保健提供者越來越依賴非侵入性成像來有效地對患者進行分類，減少不必要的心導管檢查，並提高整體護理品質。這種轉變得到了最新臨床指南的支持，這些指南承認非侵入性手術（尤其是CCTA和心臟MRI）的診斷和預後價值。消費行為也影響市場動態，越來越多的患者積極尋求更安全的診斷方案並參與預防性篩檢計畫。此外，人工智慧成像工具的出現正在提高生產力，降低診斷變異性，並使全科醫生和非專科醫生更容易獲得高級解讀。醫院網路和診斷影像中心也正在採用這些技術，以最佳化資源利用率、縮短診斷時間並提高病患吞吐量。許多國家的報銷結構正在逐步調整，以適應這些變化，使非侵入性影像對醫療保健提供者更具經濟可行性。最後，在人口老化、久坐不動的生活方式和不良飲食習慣的推動下，已開發國家和開發中國家心血管疾病的盛行率都在上升，這推動了對精準早期診斷工具的強勁且持續的需求。這些因素共同推動了全球非侵入性冠狀動脈成像市場的快速擴張。

部分

模態（超音波心臟檢查、心臟電腦斷層掃描、心臟磁振造影、放射性核種心臟影像）；最終使用者（醫院最終使用者、診斷影像中心最終使用者、研究機構最終使用者）

受訪公司範例

  • Abbott Laboratories
  • Arterys Inc.
  • Boston Scientific Corporation
  • Canon Medical Systems Corporation
  • Carestream Health, Inc.
  • Circle Cardiovascular Imaging Inc.
  • Esaote SpA
  • Fujifilm Holdings Corporation
  • GE Healthcare
  • HeartFlow, Inc.
  • Hitachi Medical Corporation
  • Hologic, Inc.
  • NeoSoft LLC
  • Neusoft Corporation
  • Philips Healthcare
  • Pie Medical Imaging
  • Positron Corporation
  • Samsung Medison Co., Ltd.
  • Siemens Healthineers
  • Viatronix, Inc.

人工智慧整合

我們正在利用有效的專家內容和人工智慧工具來改變市場和競爭情報。

Global Industry Analysts 沒有遵循查詢 LLM 或特定產業SLM 的典型規範，而是建立了一個來自世界各地專家的精選內容庫，其中包括影片錄像、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地和進出口（成品和原始設備製造商）情況預測其競爭地位的變化。這種複雜而多面的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP32371

Global Non-invasive Coronary Imaging Market to Reach US$530.6 Million by 2030

The global market for Non-invasive Coronary Imaging estimated at US$392.3 Million in the year 2024, is expected to reach US$530.6 Million by 2030, growing at a CAGR of 5.2% over the analysis period 2024-2030. Echocardiography, one of the segments analyzed in the report, is expected to record a 3.5% CAGR and reach US$204.8 Million by the end of the analysis period. Growth in the Cardiac Computed Tomography segment is estimated at 6.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$106.9 Million While China is Forecast to Grow at 7.9% CAGR

The Non-invasive Coronary Imaging market in the U.S. is estimated at US$106.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$104.0 Million by the year 2030 trailing a CAGR of 7.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.6% and 5.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.

Global Non-Invasive Coronary Imaging Market - Key Trends & Drivers Summarized

How Is Non-Invasive Coronary Imaging Changing the Game in Cardiovascular Diagnosis?

Non-invasive coronary imaging is revolutionizing the landscape of cardiovascular diagnostics, offering clinicians safer, faster, and highly accurate methods to assess coronary artery disease (CAD) without the need for catheter-based procedures. Traditional coronary angiography, while effective, involves significant patient risk due to its invasive nature, including potential vascular injury, allergic reactions to contrast agents, and post-procedure recovery time. In contrast, non-invasive techniques such as coronary computed tomography angiography (CCTA), cardiac magnetic resonance imaging (CMR), and positron emission tomography (PET) are enabling high-resolution visualization of coronary vessels with reduced procedural risk. These technologies have become pivotal in detecting plaque buildup, assessing stenosis, and evaluating overall heart function. Patients benefit significantly from quicker turnaround times, minimal discomfort, and reduced hospital stays, while physicians gain access to detailed anatomical and functional data that supports more informed treatment decisions. Additionally, the ability of non-invasive imaging tools to detect subclinical atherosclerosis-well before symptoms appear-has made them indispensable in preventive cardiology. The integration of functional assessment through methods like fractional flow reserve derived from CT (FFR-CT) is also bridging the gap between anatomical imaging and physiological insight, allowing more accurate identification of ischemia-causing lesions. As cardiovascular disease remains the leading cause of mortality globally, the role of non-invasive imaging in early detection and disease management is only expected to grow stronger.

What Role Does Technology Play in Elevating Diagnostic Accuracy and Efficiency?

Advancements in imaging technologies are central to the growing reliability and adoption of non-invasive coronary imaging solutions. The evolution of CT scanners-marked by faster acquisition speeds, reduced radiation exposure, and improved spatial resolution-has made coronary CT angiography a frontline tool for evaluating patients with suspected coronary artery disease. Simultaneously, cardiac MRI is becoming more widely used to assess myocardial perfusion, viability, and fibrosis without exposing patients to ionizing radiation. The integration of artificial intelligence and machine learning into imaging platforms is further amplifying diagnostic accuracy, allowing for automated detection of stenosis, plaque characterization, and risk stratification based on large-scale data analysis. These technologies also streamline workflow, enabling radiologists and cardiologists to interpret scans faster and with greater consistency. Dual-energy CT and photon-counting CT are the next generation of imaging innovations, providing enhanced tissue contrast and reducing artifacts that previously hindered coronary visualization. Moreover, functional imaging techniques such as stress CMR and PET scans now offer highly precise insights into myocardial blood flow and perfusion defects, which are critical for determining the need for revascularization procedures. Interoperability with electronic health records (EHRs) and cloud-based sharing systems allows for seamless data integration and second-opinion consultations across institutions. These technological leaps are not just improving accuracy-they're reshaping the diagnostic pathway to be faster, more patient-friendly, and highly personalized.

Are Shifting Clinical Practices and Patient Preferences Driving Adoption?

Changing clinical practices, along with evolving patient expectations, are playing a pivotal role in the increased demand for non-invasive coronary imaging modalities. Cardiologists and general practitioners are now more inclined to recommend non-invasive imaging as a first-line diagnostic option for stable chest pain and risk assessment, especially with the growing body of evidence supporting its clinical efficacy. Guidelines from prominent organizations such as the American College of Cardiology and the European Society of Cardiology increasingly favor non-invasive modalities due to their proven ability to reduce unnecessary invasive procedures and associated complications. From the patient's perspective, the preference for non-invasive, outpatient-based diagnostics is stronger than ever, driven by a desire for convenience, lower anxiety levels, and quicker recovery. This is particularly relevant in older populations and those with multiple comorbidities, where invasive testing poses higher risks. Non-invasive options are also more scalable in telemedicine and remote healthcare models, allowing diagnostic services to be extended to patients in rural and underserved areas. Furthermore, the rising prevalence of lifestyle-related risk factors such as diabetes, obesity, and hypertension is prompting earlier and more frequent cardiovascular screening, especially in asymptomatic high-risk groups. Hospitals and imaging centers are responding to these shifts by investing in multi-modality imaging suites and expanding cardiology service lines to accommodate outpatient diagnostics. All these trends point toward a significant shift in both provider strategy and patient mindset, reinforcing the long-term adoption of non-invasive coronary imaging across healthcare systems worldwide.

What’s Powering the Rapid Growth of the Non-Invasive Coronary Imaging Market?

The growth in the non-invasive coronary imaging market is driven by several factors spanning technological innovation, evolving clinical pathways, and shifts in healthcare delivery systems. One of the foremost drivers is the advancement of imaging platforms capable of delivering detailed, real-time visualization of coronary anatomy and function without the inherent risks of invasive procedures. Continuous improvements in scanner speed, image resolution, and post-processing software have significantly broadened the clinical utility of these modalities. On the end-user side, healthcare providers are increasingly relying on non-invasive imaging to triage patients efficiently, reduce unnecessary cardiac catheterizations, and improve overall care quality. This shift is supported by updated clinical guidelines that recognize the diagnostic and prognostic value of non-invasive techniques, particularly CCTA and cardiac MRI. Consumer behavior is also influencing market dynamics, with a growing number of patients actively seeking safer diagnostic options and participating in preventive health screening programs. Additionally, the emergence of AI-enabled imaging tools has enhanced productivity, reduced diagnostic variability, and made advanced interpretation more accessible to general practitioners and non-specialist providers. Hospital networks and imaging centers are also embracing these technologies to optimize resource utilization, shorten diagnostic timelines, and improve patient throughput. Reimbursement structures in many countries are gradually aligning with these shifts, making non-invasive imaging financially viable for providers. Finally, rising cardiovascular disease prevalence across both developed and developing nations-driven by aging populations, sedentary lifestyles, and poor dietary habits-is creating a robust and ongoing demand for accurate, early-stage diagnostic tools. Together, these factors are fueling the rapid global expansion of the non-invasive coronary imaging market.

SCOPE OF STUDY:

The report analyzes the Non-invasive Coronary Imaging market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Modality (Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging, Radionuclide Cardiac Imaging); End-Use (Hospitals End-Use, Diagnostic Imaging Centers End-Use, Research Institutes End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • Abbott Laboratories
  • Arterys Inc.
  • Boston Scientific Corporation
  • Canon Medical Systems Corporation
  • Carestream Health, Inc.
  • Circle Cardiovascular Imaging Inc.
  • Esaote S.p.A.
  • Fujifilm Holdings Corporation
  • GE Healthcare
  • HeartFlow, Inc.
  • Hitachi Medical Corporation
  • Hologic, Inc.
  • NeoSoft LLC
  • Neusoft Corporation
  • Philips Healthcare
  • Pie Medical Imaging
  • Positron Corporation
  • Samsung Medison Co., Ltd.
  • Siemens Healthineers
  • Viatronix, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Non-invasive Coronary Imaging - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Shift Toward Early Cardiovascular Risk Detection Throws the Spotlight on Non-Invasive Imaging Modalities
    • Increased Patient Preference for Radiation-Free and Painless Diagnostics Strengthens the Business Case for Non-Invasive Imaging
    • Surging Global Burden of Coronary Artery Disease Propels Growth Across Diagnostic Ecosystems
    • Integration of Functional Imaging and Anatomical Mapping Expands the Addressable Market Opportunity in Complex Cases
    • Widespread Adoption of AI-Enhanced Image Interpretation Drives Diagnostic Accuracy and Workflow Efficiency
    • Advancements in CT and MRI Technologies Accelerate Demand for High-Resolution Non-Invasive Cardiac Imaging
    • Rising Utilization in Preventive Health Programs Spurs Growth in Asymptomatic and At-Risk Populations
    • Emergence of Hybrid Imaging Platforms Strengthens Clinical Relevance and Adoption Across Hospital Systems
    • Growth in Outpatient Cardiology Services and Diagnostic Clinics Sustains Market Expansion
    • Remote Diagnostics and Teleradiology Integration Opens New Avenues in Underserved and Rural Markets
    • Increasing Emphasis on Patient Safety and Procedure Efficiency Spurs Transition from Invasive to Non-Invasive Modalities
    • Consumer Awareness and Digital Health Trends Generate Demand for Non-Invasive, Personalized Cardiac Assessments
    • Infrastructure Modernization and Cardiac Center Investments in Emerging Economies Fuel Market Penetration
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Non-invasive Coronary Imaging Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Non-invasive Coronary Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Non-invasive Coronary Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Echocardiography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Echocardiography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Echocardiography by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Cardiac Computed Tomography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Cardiac Computed Tomography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Cardiac Computed Tomography by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Cardiac Magnetic Resonance Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Cardiac Magnetic Resonance Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Cardiac Magnetic Resonance Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Radionuclide Cardiac Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Radionuclide Cardiac Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Radionuclide Cardiac Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Diagnostic Imaging Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Diagnostic Imaging Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Diagnostic Imaging Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Non-invasive Coronary Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • JAPAN
    • Non-invasive Coronary Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • CHINA
    • Non-invasive Coronary Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • EUROPE
    • Non-invasive Coronary Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Non-invasive Coronary Imaging by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Non-invasive Coronary Imaging by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • FRANCE
    • Non-invasive Coronary Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • GERMANY
    • Non-invasive Coronary Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Non-invasive Coronary Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Non-invasive Coronary Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Non-invasive Coronary Imaging by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Non-invasive Coronary Imaging by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Non-invasive Coronary Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • INDIA
    • Non-invasive Coronary Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Non-invasive Coronary Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Non-invasive Coronary Imaging by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Non-invasive Coronary Imaging by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Non-invasive Coronary Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Non-invasive Coronary Imaging by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Non-invasive Coronary Imaging by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • AFRICA
    • Non-invasive Coronary Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030

IV. COMPETITION